46 related articles for article (PubMed ID: 28796347)
1. Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
VandenBussche CJ; Allison DB; Graham MK; Charu V; Lennon AM; Wolfgang CL; Hruban RH; Heaphy CM
Cancer Cytopathol; 2017 Jul; 125(7):544-551. PubMed ID: 28371511
[TBL] [Abstract][Full Text] [Related]
2. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel gene fusion in ALT positive osteosarcoma.
Mason-Osann E; Dai A; Floro J; Lock YJ; Reiss M; Gali H; Matschulat A; Labadorf A; Flynn RL
Oncotarget; 2018 Aug; 9(67):32868-32880. PubMed ID: 30214690
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations associated with ALTered telomeres.
Brosnan-Cashman JA; Graham MK; Heaphy CM
Oncotarget; 2018 Sep; 9(73):33739-33740. PubMed ID: 30333904
[No Abstract] [Full Text] [Related]
5. Structural and biochemical characterization of DAXX-ATRX interaction.
Li Z; Zhao D; Xiang B; Li H
Protein Cell; 2017 Oct; 8(10):762-766. PubMed ID: 28875283
[No Abstract] [Full Text] [Related]
6. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia.
Pergaris A; Genaris I; Stergiou IE; Klijanienko J; Papadakos SP; Theocharis S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958340
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis.
Wen T; Chen QY
Front Oncol; 2021; 11():806974. PubMed ID: 35087762
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
10. ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
MacKenzie D; Watters AK; To JT; Young MW; Muratori J; Wilkoff MH; Abraham RG; Plummer MM; Zhang D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069193
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.
Machado I; Giner F; Lavernia J; Cruz J; Traves V; Requena C; Llombart B; López-Guerrero JA; Llombart-Bosch A
Histol Histopathol; 2021 Jan; 36(1):3-18. PubMed ID: 32885407
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Death Domain-Associated Protein 6 in Different Endometrial Carcinomas Histotypes.
Jin C; Hacking S; Komforti MK; Nasim M
Biomark Insights; 2019; 14():1177271919864892. PubMed ID: 31384126
[TBL] [Abstract][Full Text] [Related]
13. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells.
Aoshima K; Fukui Y; Gulay KCM; Erdemsurakh O; Morita A; Kobayashi A; Kimura T
BMC Vet Res; 2018 Oct; 14(1):301. PubMed ID: 30285832
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas.
Panse G; Chrisinger JS; Leung CH; Ingram DR; Khan S; Wani K; Lin H; Lazar AJ; Wang WL
Histopathology; 2018 Jan; 72(2):239-247. PubMed ID: 28796347
[TBL] [Abstract][Full Text] [Related]
15. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
[TBL] [Abstract][Full Text] [Related]
16. ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.
Chou A; Itchins M; de Reuver PR; Arena J; Clarkson A; Sheen A; Sioson L; Cheung V; Perren A; Nahm C; Mittal A; Samra JS; Pajic M; Gill AJ
Hum Pathol; 2018 Dec; 82():249-257. PubMed ID: 30081149
[TBL] [Abstract][Full Text] [Related]
17. Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.
Lee JC; Jeng YM; Liau JY; Tsai JH; Hsu HH; Yang CY
Mod Pathol; 2015 Aug; 28(8):1064-73. PubMed ID: 26022452
[TBL] [Abstract][Full Text] [Related]
18. ATRX and DAXX: Mechanisms and Mutations.
Dyer MA; Qadeer ZA; Valle-Garcia D; Bernstein E
Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28062559
[TBL] [Abstract][Full Text] [Related]
19. Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma.
Fan HC; Chen CM; Chi CS; Tsai JD; Chiang KL; Chang YK; Lin SZ; Harn HJ
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30625996
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
